
UK Government Invests Β£82.6 Million in AI-Driven Cancer Research
UK invests Β£82.6 million in AI cancer research. Three projects aim to enhance diagnostics and drug discovery. π§¬π°
Discover the newest research about AI innovations in π Oncology.

UK invests Β£82.6 million in AI cancer research. Three projects aim to enhance diagnostics and drug discovery. π§¬π°

Antiviral therapy reduces immune-related adverse events in HBV-positive liver cancer patients treated with immunotherapy. ππ

AI enhances personalized cancer treatment by analyzing diverse patient data, improving prognosis accuracy and clinical decision-making. π§¬π€

Next-Generation Sequencing enhances precision medicine in hepatocellular carcinoma, addressing drug resistance and improving treatment outcomes. π§¬π¬

Ensemble learning models show promise in predicting tumor deposits in rectal cancer. π©Ίπ VELM outperforms others with an AUC of 0.875.

Women entrepreneurs excelled at the UK Women in Innovation Awards, showcasing innovative health tech solutions. ππ‘

A recent study highlights a deep learning model for lung cancer detection, achieving 99.75% accuracy. π«π

Recent research evaluated LLM chatbots’ oncological knowledge using Turkish board exam questions. Claude 3.5 Sonnet excelled, highlighting AI’s potential in oncology. ππ‘

Airedale NHS Foundation Trust launches Careology app for cancer patients, enhancing treatment management and support. π±π

New AI trial aims for earlier breast cancer detection. Nearly 700,000 women to participate across 30 sites in England. π©Ίπ»